SEC Tracker
Get the app

Pelthos Therapeutics PTHS

Pelthos Therapeutics enters merger agreement with Castle Creek

Merger communication

Form
425
Filed
Importance
Routine
  1. Merger involves Pelthos and Castle Creek
  2. Castle Creek stockholders to receive 5,200,000 Pelthos shares
  3. Milestone payments of $50M to $75M based on D-Fi sales
  4. 10% of shares to be held in escrow for indemnification

Written from the 425 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Pelthos Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Protagenic Therapeutics, Inc.\new PTIX public float $7M, Sep 30, 2025
  2. Biomerica BMRA public float $7M, Nov 28, 2025
  3. Adial Pharmaceuticals ADIL public float $6M, Jun 30, 2025
  4. CV Sciences CVSI public float $7M, Jun 30, 2025
  5. Minerva Neurosciences NERV public float $7M, Jun 30, 2025